Liquid-filled balloon brachytherapy using 68Ga is effective and safe because of the short 68-minute half-life: Results of a feasibility study in the porcine coronary overstretch model

Hans Peter Stoll, Gary Hutchins, Wendy L. Winkle, Anne T. Nguyen, Dongming Hou, C. Robert Appledorn, Bernd Romeike, Keith L. March

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background - Liquid-filled balloons for coronary brachytherapy provide significant advantages over solid sources in dose homogeneity but carry the risk of life-threatening radiointoxication after balloon rupture and laboratory contamination in case of a spill. We hypothesized that the positron emitter 68Ga, with a half-life of only 68 minutes, was well suited to overcome these safety obstacles while providing full therapeutic efficacy. Methods and Results - The feasibility, efficacy, and safety of 68Ga liquid-filled balloon brachytherapy were investigated in the porcine coronary overstretch model. Four groups of 5 balloon-induced coronary lesions were irradiated with 8, 12, 16, and 24 Gy targeted to the adventitia. Ten unirradiated lesions served as controls. Segments treated with 16 or 24 Gy exhibited marked suppression of neointimal proliferation at 28-day follow-up, with quantitative parameters of intraluminal proliferation reduced to <20%. This beneficial effect was not compromised by untoward edge effects. Uninjured but irradiated vessels did not show histological signs of radiation damage. The 68Ga whole-body dose due to balloon rupture was estimated to be 5 rem/50 mCi treatment activity and compared favorably with that of 188Re (78 rem/50 mCi). Conclusions - 68Ga positron radiation suppresses neointimal proliferation at doses of 16 and 24 Gy. This biological efficacy, coupled with the attractive safety profile, suggests the selection of 68Ga as an attractive isotope for liquid-filled balloon brachytherapy.

Original languageEnglish
Pages (from-to)1793-1798
Number of pages6
JournalCirculation
Volume103
Issue number13
StatePublished - Apr 3 2001

Fingerprint

Brachytherapy
Feasibility Studies
Half-Life
Swine
Safety
Rupture
Electrons
Radiation
Adventitia
Isotopes
Therapeutics

Keywords

  • Angioplasty
  • Radioisotopes
  • Restenosis

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Liquid-filled balloon brachytherapy using 68Ga is effective and safe because of the short 68-minute half-life : Results of a feasibility study in the porcine coronary overstretch model. / Stoll, Hans Peter; Hutchins, Gary; Winkle, Wendy L.; Nguyen, Anne T.; Hou, Dongming; Appledorn, C. Robert; Romeike, Bernd; March, Keith L.

In: Circulation, Vol. 103, No. 13, 03.04.2001, p. 1793-1798.

Research output: Contribution to journalArticle

Stoll, Hans Peter ; Hutchins, Gary ; Winkle, Wendy L. ; Nguyen, Anne T. ; Hou, Dongming ; Appledorn, C. Robert ; Romeike, Bernd ; March, Keith L. / Liquid-filled balloon brachytherapy using 68Ga is effective and safe because of the short 68-minute half-life : Results of a feasibility study in the porcine coronary overstretch model. In: Circulation. 2001 ; Vol. 103, No. 13. pp. 1793-1798.
@article{cc39d329b77a40ad8de4ea5b3d1e4a3b,
title = "Liquid-filled balloon brachytherapy using 68Ga is effective and safe because of the short 68-minute half-life: Results of a feasibility study in the porcine coronary overstretch model",
abstract = "Background - Liquid-filled balloons for coronary brachytherapy provide significant advantages over solid sources in dose homogeneity but carry the risk of life-threatening radiointoxication after balloon rupture and laboratory contamination in case of a spill. We hypothesized that the positron emitter 68Ga, with a half-life of only 68 minutes, was well suited to overcome these safety obstacles while providing full therapeutic efficacy. Methods and Results - The feasibility, efficacy, and safety of 68Ga liquid-filled balloon brachytherapy were investigated in the porcine coronary overstretch model. Four groups of 5 balloon-induced coronary lesions were irradiated with 8, 12, 16, and 24 Gy targeted to the adventitia. Ten unirradiated lesions served as controls. Segments treated with 16 or 24 Gy exhibited marked suppression of neointimal proliferation at 28-day follow-up, with quantitative parameters of intraluminal proliferation reduced to <20{\%}. This beneficial effect was not compromised by untoward edge effects. Uninjured but irradiated vessels did not show histological signs of radiation damage. The 68Ga whole-body dose due to balloon rupture was estimated to be 5 rem/50 mCi treatment activity and compared favorably with that of 188Re (78 rem/50 mCi). Conclusions - 68Ga positron radiation suppresses neointimal proliferation at doses of 16 and 24 Gy. This biological efficacy, coupled with the attractive safety profile, suggests the selection of 68Ga as an attractive isotope for liquid-filled balloon brachytherapy.",
keywords = "Angioplasty, Radioisotopes, Restenosis",
author = "Stoll, {Hans Peter} and Gary Hutchins and Winkle, {Wendy L.} and Nguyen, {Anne T.} and Dongming Hou and Appledorn, {C. Robert} and Bernd Romeike and March, {Keith L.}",
year = "2001",
month = "4",
day = "3",
language = "English",
volume = "103",
pages = "1793--1798",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "13",

}

TY - JOUR

T1 - Liquid-filled balloon brachytherapy using 68Ga is effective and safe because of the short 68-minute half-life

T2 - Results of a feasibility study in the porcine coronary overstretch model

AU - Stoll, Hans Peter

AU - Hutchins, Gary

AU - Winkle, Wendy L.

AU - Nguyen, Anne T.

AU - Hou, Dongming

AU - Appledorn, C. Robert

AU - Romeike, Bernd

AU - March, Keith L.

PY - 2001/4/3

Y1 - 2001/4/3

N2 - Background - Liquid-filled balloons for coronary brachytherapy provide significant advantages over solid sources in dose homogeneity but carry the risk of life-threatening radiointoxication after balloon rupture and laboratory contamination in case of a spill. We hypothesized that the positron emitter 68Ga, with a half-life of only 68 minutes, was well suited to overcome these safety obstacles while providing full therapeutic efficacy. Methods and Results - The feasibility, efficacy, and safety of 68Ga liquid-filled balloon brachytherapy were investigated in the porcine coronary overstretch model. Four groups of 5 balloon-induced coronary lesions were irradiated with 8, 12, 16, and 24 Gy targeted to the adventitia. Ten unirradiated lesions served as controls. Segments treated with 16 or 24 Gy exhibited marked suppression of neointimal proliferation at 28-day follow-up, with quantitative parameters of intraluminal proliferation reduced to <20%. This beneficial effect was not compromised by untoward edge effects. Uninjured but irradiated vessels did not show histological signs of radiation damage. The 68Ga whole-body dose due to balloon rupture was estimated to be 5 rem/50 mCi treatment activity and compared favorably with that of 188Re (78 rem/50 mCi). Conclusions - 68Ga positron radiation suppresses neointimal proliferation at doses of 16 and 24 Gy. This biological efficacy, coupled with the attractive safety profile, suggests the selection of 68Ga as an attractive isotope for liquid-filled balloon brachytherapy.

AB - Background - Liquid-filled balloons for coronary brachytherapy provide significant advantages over solid sources in dose homogeneity but carry the risk of life-threatening radiointoxication after balloon rupture and laboratory contamination in case of a spill. We hypothesized that the positron emitter 68Ga, with a half-life of only 68 minutes, was well suited to overcome these safety obstacles while providing full therapeutic efficacy. Methods and Results - The feasibility, efficacy, and safety of 68Ga liquid-filled balloon brachytherapy were investigated in the porcine coronary overstretch model. Four groups of 5 balloon-induced coronary lesions were irradiated with 8, 12, 16, and 24 Gy targeted to the adventitia. Ten unirradiated lesions served as controls. Segments treated with 16 or 24 Gy exhibited marked suppression of neointimal proliferation at 28-day follow-up, with quantitative parameters of intraluminal proliferation reduced to <20%. This beneficial effect was not compromised by untoward edge effects. Uninjured but irradiated vessels did not show histological signs of radiation damage. The 68Ga whole-body dose due to balloon rupture was estimated to be 5 rem/50 mCi treatment activity and compared favorably with that of 188Re (78 rem/50 mCi). Conclusions - 68Ga positron radiation suppresses neointimal proliferation at doses of 16 and 24 Gy. This biological efficacy, coupled with the attractive safety profile, suggests the selection of 68Ga as an attractive isotope for liquid-filled balloon brachytherapy.

KW - Angioplasty

KW - Radioisotopes

KW - Restenosis

UR - http://www.scopus.com/inward/record.url?scp=0035799372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035799372&partnerID=8YFLogxK

M3 - Article

C2 - 11282912

AN - SCOPUS:0035799372

VL - 103

SP - 1793

EP - 1798

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 13

ER -